Vaccine.Photo: Getty

A healthcare Worker hands in surgical gloves pulling COVID-19 vaccine liquid from vial to vaccinate a patient

The Johnson & Johnson COVID-19 vaccine has little effect againstthe omicron variantaccording to a newly releasedstudy.

The report, which has not been peer reviewed yet, showed that the Johnson & Johnson shot — as well as China’s Sinopharm and Russia’s Sputnik V vaccines ­— had no neutralizing activity against the new variant.

The release of the study comes after the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention announced on Thursday that they recommend adults select either thePfizerorModernavaccines over the Johnson & Johnson shot to get vaccinated againstCOVID.

A child getting a COVID-19 vaccine dose.Getty

vaccines

Nine TTS deaths were reported following the Johnson & Johnson COVID-19 vaccine. TTS deaths were highest among females 30–39 years of age and 40–49 years of age.

“The TTS case reporting rates following Janssen [Johnson & Johnson] vaccines is higher than previous estimates in men as well as women in a wider age range,” chair of the CDC’s vaccine and safety subgroup, Dr. Keipp Talbot, said at a CDC Vaccine Advisory Panel Thursday perCNBC.

Never miss a story — sign up forPEOPLE’s free daily newsletterto stay up-to-date on the best of what PEOPLE has to offer, from juicy celebrity news to compelling human interest stories.

More than 17 million people in the United States have received the J&J vaccine,according to the CDC, while just over 285 million Americans have received the Pfizer vaccine and 187 million people got the Moderna vaccine.

source: people.com